Cargando…
Evaluation of prevalance and risk factors for bloodstream infection in severe coronavirus disease 2019 (COVID-19) patients
OBJECTIVES: In this study, we sought to determine the prevalence of bloodstream infection (BSI) in severe coronavirus disease 2019 (COVID-19) patients and to determine the risk factors of BSI in critical COVID-19 patients. DESIGN: Retrospective, descriptive study between March 2020 and January 2021....
Autores principales: | Erbay, Kubra, Ozger, Hasan Selcuk, Guzel Tunccan, Ozlem, Gaygısız, Ümmügülsüm, Buyukkoruk, Merve, Sultanova, Fidan, Yıldız, Mehmet, Boyacı Dündar, Nazlıhan, Aydoğdu, Müge, Bozdayi, Gulendam, Dizbay, Murat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614839/ https://www.ncbi.nlm.nih.gov/pubmed/36310789 http://dx.doi.org/10.1017/ash.2021.254 |
Ejemplares similares
-
Evaluation of prevalence and risk factors for bloodstream infection in severe coronavirus disease 2019 (COVID-19) patients – CORRIGENDUM
por: Erbay, Kubra, et al.
Publicado: (2022) -
Monoclonal outbreak of Ralstonia solanacearum catheter-related bloodstream infection associated with contaminated package of normal saline solution in a tertiary care hospital
por: GÜZEL TUNÇCAN, Özlem, et al.
Publicado: (2021) -
The factors predicting pneumonia in COVID-19 patients: preliminary results from a university hospital in Turkey
por: ÖZGER, Selçuk H, et al.
Publicado: (2020) -
Assessing neutrophil-derived ROS production at the bedside: a potential prognostic tool in severe COVID-19 cases
por: Dündar, Nazlıhan Boyacı, et al.
Publicado: (2023) -
Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19
por: Satış, Hasan, et al.
Publicado: (2021)